Harold Shlevin plan to sell securities of GALECTIN THERAPEUTICS INCORPORATED under Form 144

Harold Shlevin filed Form 144 to notify SEC of plan to sell 22268 units of GALECTIN THERAPEUTICS INCORPORATED securities around 2026-06-29, with aggregate market value of $112,211.88. The total outstanding units is 65856898.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 months include: On 06/26/2026, sold 7732 units for $38680.00;